3 results
Primary objective: Determine whether treatment with a PI3K inhibitor (BYL719 or buparlisib) plus letrozole leads to an increase in pathologic response compared to treatment with placebo plus letrozole in patients with hormone receptor-positive HER2-…
We propose a phase II study (intervention) in patients with severe generalized recessive dystrophic EB receiving reduced toxicity conditioning chemotherapy followe by cord blood transplantation with co-infusion of mesenchymal stromal cell units.…
The primary objective of this study is to objectify the efficacy of TORS compared to CPAP and MAD. Secondary objectives:To determine long term outcomes of TORS compared to CPAP or MAD.To compare functional sleep outcomes in TORS and CPAP/MAD…